ACLY and esophageal squamous cell carcinoma: As shown in Supplementary Fig. 7a, b, ACLY Y542A, Y652A, and ALDOA Y174A, Y302A, or Y328A effectively inhibited the invasion of FAK-overexpressing ESCC cells.